

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.82926367 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 4.66192967 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.58740846 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.51035731 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.38194896 |
| 6 | DNA deamination (GO:0045006) | 4.18168618 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 4.16370627 |
| 8 | negative regulation of cell killing (GO:0031342) | 4.13852520 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.13852520 |
| 10 | immunoglobulin mediated immune response (GO:0016064) | 3.80863724 |
| 11 | positive regulation of B cell differentiation (GO:0045579) | 3.63834033 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.60669958 |
| 13 | proteasome assembly (GO:0043248) | 3.47476915 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.35504118 |
| 15 | L-phenylalanine metabolic process (GO:0006558) | 3.35504118 |
| 16 | response to interferon-beta (GO:0035456) | 3.30395553 |
| 17 | detection of bacterium (GO:0016045) | 3.28267438 |
| 18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.25638140 |
| 19 | L-phenylalanine catabolic process (GO:0006559) | 3.25638140 |
| 20 | L-methionine salvage (GO:0071267) | 3.16170237 |
| 21 | L-methionine biosynthetic process (GO:0071265) | 3.16170237 |
| 22 | amino acid salvage (GO:0043102) | 3.16170237 |
| 23 | neutrophil activation (GO:0042119) | 3.15408203 |
| 24 | detection of other organism (GO:0098543) | 3.14322005 |
| 25 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.14082728 |
| 26 | regulation of B cell differentiation (GO:0045577) | 3.13392552 |
| 27 | aromatic amino acid family catabolic process (GO:0009074) | 3.13094811 |
| 28 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.10789505 |
| 29 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.09875069 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.07834449 |
| 31 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.06605258 |
| 32 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.06571182 |
| 33 | regulation of B cell apoptotic process (GO:0002902) | 3.06552767 |
| 34 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.06209255 |
| 35 | actin nucleation (GO:0045010) | 3.01679831 |
| 36 | viral transcription (GO:0019083) | 3.01022736 |
| 37 | positive thymic T cell selection (GO:0045059) | 3.00872223 |
| 38 | regulation of mast cell degranulation (GO:0043304) | 3.00415565 |
| 39 | negative regulation of B cell apoptotic process (GO:0002903) | 2.99589584 |
| 40 | glycine metabolic process (GO:0006544) | 2.98595272 |
| 41 | autophagic vacuole fusion (GO:0000046) | 2.97481816 |
| 42 | tolerance induction (GO:0002507) | 2.97441951 |
| 43 | ribosomal small subunit biogenesis (GO:0042274) | 2.96508280 |
| 44 | positive regulation of antigen processing and presentation (GO:0002579) | 2.96346129 |
| 45 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.96224859 |
| 46 | maturation of SSU-rRNA (GO:0030490) | 2.96050716 |
| 47 | folic acid metabolic process (GO:0046655) | 2.95920091 |
| 48 | tryptophan catabolic process (GO:0006569) | 2.95294659 |
| 49 | indole-containing compound catabolic process (GO:0042436) | 2.95294659 |
| 50 | indolalkylamine catabolic process (GO:0046218) | 2.95294659 |
| 51 | organelle membrane fusion (GO:0090174) | 2.94635707 |
| 52 | B cell receptor signaling pathway (GO:0050853) | 2.94459884 |
| 53 | regulation of gamma-delta T cell activation (GO:0046643) | 2.93891172 |
| 54 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.93305267 |
| 55 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.92071886 |
| 56 | heme biosynthetic process (GO:0006783) | 2.89109598 |
| 57 | translational termination (GO:0006415) | 2.88873181 |
| 58 | purine nucleobase biosynthetic process (GO:0009113) | 2.88044451 |
| 59 | leukocyte degranulation (GO:0043299) | 2.87259501 |
| 60 | granulocyte activation (GO:0036230) | 2.87159321 |
| 61 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.86916569 |
| 62 | nucleoside salvage (GO:0043174) | 2.86225633 |
| 63 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.85835612 |
| 64 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.85415096 |
| 65 | B cell mediated immunity (GO:0019724) | 2.84476950 |
| 66 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.84120743 |
| 67 | peptidyl-histidine modification (GO:0018202) | 2.83824109 |
| 68 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.82767988 |
| 69 | sulfur amino acid catabolic process (GO:0000098) | 2.82668432 |
| 70 | respiratory chain complex IV assembly (GO:0008535) | 2.81697371 |
| 71 | formation of translation preinitiation complex (GO:0001731) | 2.80869835 |
| 72 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.79665630 |
| 73 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.79665630 |
| 74 | regulation of mast cell activation (GO:0033003) | 2.79619803 |
| 75 | response to peptidoglycan (GO:0032494) | 2.79258082 |
| 76 | aldehyde catabolic process (GO:0046185) | 2.78757949 |
| 77 | regulation of antigen processing and presentation (GO:0002577) | 2.78553185 |
| 78 | modulation by symbiont of host defense response (GO:0052031) | 2.78251757 |
| 79 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.78251757 |
| 80 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.78251757 |
| 81 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.78251757 |
| 82 | modulation by symbiont of host immune response (GO:0052553) | 2.78251757 |
| 83 | positive regulation by symbiont of host defense response (GO:0052509) | 2.78251757 |
| 84 | regulation of germinal center formation (GO:0002634) | 2.77985158 |
| 85 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.77932561 |
| 86 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.77932561 |
| 87 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.77932561 |
| 88 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.76152363 |
| 89 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.75978834 |
| 90 | negative regulation of ligase activity (GO:0051352) | 2.75656376 |
| 91 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.75656376 |
| 92 | cellular metabolic compound salvage (GO:0043094) | 2.75413337 |
| 93 | cotranslational protein targeting to membrane (GO:0006613) | 2.75048240 |
| 94 | heme metabolic process (GO:0042168) | 2.74834251 |
| 95 | ribosomal large subunit biogenesis (GO:0042273) | 2.72942984 |
| 96 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.72848716 |
| 97 | protein targeting to ER (GO:0045047) | 2.72671279 |
| 98 | tryptophan metabolic process (GO:0006568) | 2.71943503 |
| 99 | translational elongation (GO:0006414) | 2.71812102 |
| 100 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.71205996 |
| 101 | mature B cell differentiation involved in immune response (GO:0002313) | 2.71155592 |
| 102 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.71037412 |
| 103 | negative regulation of innate immune response (GO:0045824) | 2.70096011 |
| 104 | positive regulation of granulocyte differentiation (GO:0030854) | 2.69711196 |
| 105 | cellular response to type I interferon (GO:0071357) | 2.69037027 |
| 106 | type I interferon signaling pathway (GO:0060337) | 2.69037027 |
| 107 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.68612714 |
| 108 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.68441179 |
| 109 | defense response to protozoan (GO:0042832) | 2.68165240 |
| 110 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.68058853 |
| 111 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.67673519 |
| 112 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.67673519 |
| 113 | nucleobase biosynthetic process (GO:0046112) | 2.67373154 |
| 114 | protein localization to endoplasmic reticulum (GO:0070972) | 2.67170026 |
| 115 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.67066475 |
| 116 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.66736645 |
| 117 | negative T cell selection (GO:0043383) | 2.66551644 |
| 118 | chaperone-mediated protein transport (GO:0072321) | 2.66482391 |
| 119 | serine family amino acid biosynthetic process (GO:0009070) | 2.66021441 |
| 120 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.65866071 |
| 121 | negative thymic T cell selection (GO:0045060) | 2.65824160 |
| 122 | response to type I interferon (GO:0034340) | 2.65449836 |
| 123 | termination of RNA polymerase III transcription (GO:0006386) | 2.65030991 |
| 124 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.65030991 |
| 125 | cysteine metabolic process (GO:0006534) | 2.64660003 |
| 126 | serine family amino acid catabolic process (GO:0009071) | 2.64069848 |
| 127 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.63708434 |
| 128 | sulfur amino acid biosynthetic process (GO:0000097) | 2.62325602 |
| 129 | purine nucleotide salvage (GO:0032261) | 2.60442878 |
| 130 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.59918159 |
| 131 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.59785217 |
| 132 | Peyers patch development (GO:0048541) | 2.59785217 |
| 133 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.59412768 |
| 134 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.58688813 |
| 135 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.58688813 |
| 136 | NADH dehydrogenase complex assembly (GO:0010257) | 2.58688813 |
| 137 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.58261779 |
| 138 | kynurenine metabolic process (GO:0070189) | 2.58173528 |
| 139 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.58001317 |
| 140 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.58001317 |
| 141 | cytidine deamination (GO:0009972) | 2.56728586 |
| 142 | cytidine metabolic process (GO:0046087) | 2.56728586 |
| 143 | cytidine catabolic process (GO:0006216) | 2.56728586 |
| 144 | cytochrome complex assembly (GO:0017004) | 2.54622049 |
| 145 | protein complex biogenesis (GO:0070271) | 2.54588591 |
| 146 | oxidative phosphorylation (GO:0006119) | 2.54569365 |
| 147 | S-adenosylmethionine metabolic process (GO:0046500) | 2.53770065 |
| 148 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.53725027 |
| 149 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.53703556 |
| 150 | thrombin receptor signaling pathway (GO:0070493) | 2.53700327 |
| 151 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.53521064 |
| 152 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.53521064 |
| 153 | glyoxylate metabolic process (GO:0046487) | 2.53316737 |
| 154 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.53218210 |
| 155 | serine family amino acid metabolic process (GO:0009069) | 2.52938111 |
| 156 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.52660936 |
| 157 | aromatic amino acid family metabolic process (GO:0009072) | 2.51722283 |
| 158 | response to protozoan (GO:0001562) | 2.51390249 |
| 159 | purine-containing compound salvage (GO:0043101) | 2.51295138 |
| 160 | respiratory burst (GO:0045730) | 2.50969729 |
| 161 | methionine metabolic process (GO:0006555) | 2.50964840 |
| 162 | response to interleukin-15 (GO:0070672) | 2.50559174 |
| 163 | lysine metabolic process (GO:0006553) | 2.48654689 |
| 164 | lysine catabolic process (GO:0006554) | 2.48654689 |
| 165 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.47836400 |
| 166 | translational initiation (GO:0006413) | 2.47541435 |
| 167 | GDP-mannose metabolic process (GO:0019673) | 2.47355701 |
| 168 | regulation of regulatory T cell differentiation (GO:0045589) | 2.46978933 |
| 169 | myeloid cell activation involved in immune response (GO:0002275) | 2.46381740 |
| 170 | lipoxygenase pathway (GO:0019372) | 2.46180165 |
| 171 | high-density lipoprotein particle remodeling (GO:0034375) | 2.45825323 |
| 172 | translation (GO:0006412) | 2.45567042 |
| 173 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.45432402 |
| 174 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.45351634 |
| 175 | urea cycle (GO:0000050) | 2.44942682 |
| 176 | urea metabolic process (GO:0019627) | 2.44942682 |
| 177 | sequestering of actin monomers (GO:0042989) | 2.44836411 |
| 178 | iron-sulfur cluster assembly (GO:0016226) | 2.44681809 |
| 179 | metallo-sulfur cluster assembly (GO:0031163) | 2.44681809 |
| 180 | leukocyte aggregation (GO:0070486) | 2.44523518 |
| 181 | megakaryocyte development (GO:0035855) | 2.44056523 |
| 182 | regulation of leukocyte degranulation (GO:0043300) | 2.43246045 |
| 183 | response to host immune response (GO:0052572) | 2.41784346 |
| 184 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.41784346 |
| 185 | positive T cell selection (GO:0043368) | 2.38892549 |
| 186 | deoxyribonucleotide catabolic process (GO:0009264) | 2.38057714 |
| 187 | mast cell activation (GO:0045576) | 2.37223375 |
| 188 | cellular response to interferon-beta (GO:0035458) | 2.36646974 |
| 189 | negative regulation of T cell apoptotic process (GO:0070233) | 2.36207641 |
| 190 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.36196187 |
| 191 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.35909309 |
| 192 | actin filament polymerization (GO:0030041) | 2.35000506 |
| 193 | regulation of granulocyte differentiation (GO:0030852) | 2.33734097 |
| 194 | positive regulation of T cell migration (GO:2000406) | 2.32256511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.35375995 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.59307243 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.54398458 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.12845502 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.09494569 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.06901747 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.93339147 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.81427660 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.78181952 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.68974299 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.66017724 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.63561520 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.58603514 |
| 14 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.53996049 |
| 15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.52439477 |
| 16 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.36006927 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.34327785 |
| 18 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.30605711 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.30122873 |
| 20 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.29395063 |
| 21 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.28491884 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.24933737 |
| 23 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.21787319 |
| 24 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.12305878 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08882683 |
| 26 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.07274730 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 2.02173967 |
| 28 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.00225534 |
| 29 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.98981335 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.98887252 |
| 31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.98313620 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.95868494 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.94583728 |
| 34 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.94484507 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.90671941 |
| 36 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.87369798 |
| 37 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86010199 |
| 38 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.83745854 |
| 39 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.83285564 |
| 40 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.83002982 |
| 41 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.81352070 |
| 42 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.80848500 |
| 43 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.80257682 |
| 44 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.78591612 |
| 45 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.78582909 |
| 46 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.77304435 |
| 47 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.76404807 |
| 48 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75133737 |
| 49 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.74869017 |
| 50 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.74440097 |
| 51 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.74097732 |
| 52 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.73966318 |
| 53 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.72522961 |
| 54 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.68744262 |
| 55 | MYB_26560356_Chip-Seq_TH1_Human | 1.68006625 |
| 56 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.67657408 |
| 57 | MAF_26560356_Chip-Seq_TH2_Human | 1.66327857 |
| 58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.65016514 |
| 59 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.63972326 |
| 60 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.62927277 |
| 61 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.61900662 |
| 62 | SPI1_23127762_ChIP-Seq_K562_Human | 1.61272841 |
| 63 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59844732 |
| 64 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.58444129 |
| 65 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.58384159 |
| 66 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.55354992 |
| 67 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.54167224 |
| 68 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.53674243 |
| 69 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.53447752 |
| 70 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.52264773 |
| 71 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.52038958 |
| 72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.51862078 |
| 73 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.51409335 |
| 74 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.50908251 |
| 75 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.50769142 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.50041343 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.48926470 |
| 78 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48124325 |
| 79 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.46748709 |
| 80 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.46333713 |
| 81 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.45947109 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 1.45889863 |
| 83 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.44479988 |
| 84 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.40551153 |
| 85 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40239667 |
| 86 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.39300199 |
| 87 | P68_20966046_ChIP-Seq_HELA_Human | 1.38765885 |
| 88 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.36994620 |
| 89 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.35881494 |
| 90 | GATA1_22025678_ChIP-Seq_K562_Human | 1.35150521 |
| 91 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.34973260 |
| 92 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.34516459 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30985641 |
| 94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30761785 |
| 95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30166096 |
| 96 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29300571 |
| 97 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.28808263 |
| 98 | P300_27268052_Chip-Seq_Bcells_Human | 1.25485080 |
| 99 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.25462328 |
| 100 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24283269 |
| 101 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.22801863 |
| 102 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22671612 |
| 103 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21439550 |
| 104 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20800615 |
| 105 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20731479 |
| 106 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20555598 |
| 107 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20093598 |
| 108 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19668994 |
| 109 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.18946623 |
| 110 | MYC_22102868_ChIP-Seq_BL_Human | 1.18780722 |
| 111 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18697134 |
| 112 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.18405213 |
| 113 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18217648 |
| 114 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.15760741 |
| 115 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.15746845 |
| 116 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.15456664 |
| 117 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.15051423 |
| 118 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.14640111 |
| 119 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.14532021 |
| 120 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.14004200 |
| 121 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13812140 |
| 122 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13203290 |
| 123 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.12638578 |
| 124 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.12528614 |
| 125 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12472810 |
| 126 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.11568449 |
| 127 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.11101803 |
| 128 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.10824271 |
| 129 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.09676165 |
| 130 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.08373398 |
| 131 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.08150960 |
| 132 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07931602 |
| 133 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07399336 |
| 134 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06707586 |
| 135 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.04428099 |
| 136 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.04368099 |
| 137 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.03195233 |
| 138 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.01517661 |
| 139 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.01328430 |
| 140 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.01242006 |
| 141 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.00851756 |
| 142 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99963321 |
| 143 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99671549 |
| 144 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.99010232 |
| 145 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.97604427 |
| 146 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97085490 |
| 147 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95872875 |
| 148 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93716078 |
| 149 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.93684154 |
| 150 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93447719 |
| 151 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.92692715 |
| 152 | MAF_26560356_Chip-Seq_TH1_Human | 0.90578798 |
| 153 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.90369613 |
| 154 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.89777363 |
| 155 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.89670338 |
| 156 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.89506215 |
| 157 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.88665854 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.18678441 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 4.13475300 |
| 3 | MP0005360_urolithiasis | 3.99518703 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.31610480 |
| 5 | MP0009840_abnormal_foam_cell | 3.13308542 |
| 6 | MP0005365_abnormal_bile_salt | 3.01865747 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 2.83976037 |
| 8 | MP0003656_abnormal_erythrocyte_physiolo | 2.77049729 |
| 9 | MP0003693_abnormal_embryo_hatching | 2.58091422 |
| 10 | MP0003186_abnormal_redox_activity | 2.46889134 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.42547716 |
| 12 | MP0005083_abnormal_biliary_tract | 2.40109989 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.35927781 |
| 14 | MP0009785_altered_susceptibility_to | 2.32212369 |
| 15 | MP0003303_peritoneal_inflammation | 2.31446262 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.29787990 |
| 17 | MP0001764_abnormal_homeostasis | 2.20714225 |
| 18 | MP0003436_decreased_susceptibility_to | 2.10781052 |
| 19 | MP0003195_calcinosis | 1.96440097 |
| 20 | MP0005671_abnormal_response_to | 1.88935624 |
| 21 | MP0009333_abnormal_splenocyte_physiolog | 1.84560267 |
| 22 | MP0001666_abnormal_nutrient_absorption | 1.81120958 |
| 23 | MP0005332_abnormal_amino_acid | 1.80738538 |
| 24 | MP0003763_abnormal_thymus_physiology | 1.76932677 |
| 25 | MP0005025_abnormal_response_to | 1.74679339 |
| 26 | MP0000685_abnormal_immune_system | 1.73452380 |
| 27 | MP0006036_abnormal_mitochondrial_physio | 1.68947667 |
| 28 | MP0010329_abnormal_lipoprotein_level | 1.67216323 |
| 29 | MP0004957_abnormal_blastocyst_morpholog | 1.67061500 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.60124333 |
| 31 | MP0001800_abnormal_humoral_immune | 1.56448351 |
| 32 | MP0009278_abnormal_bone_marrow | 1.55764230 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.54827008 |
| 34 | MP0008260_abnormal_autophagy | 1.52607191 |
| 35 | MP0000609_abnormal_liver_physiology | 1.51692764 |
| 36 | MP0008469_abnormal_protein_level | 1.51077443 |
| 37 | MP0005000_abnormal_immune_tolerance | 1.49111151 |
| 38 | MP0003718_maternal_effect | 1.47507436 |
| 39 | MP0002723_abnormal_immune_serum | 1.44923428 |
| 40 | MP0009643_abnormal_urine_homeostasis | 1.44373601 |
| 41 | MP0003252_abnormal_bile_duct | 1.42810640 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.42562756 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.41435331 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.41184759 |
| 45 | MP0004147_increased_porphyrin_level | 1.41165190 |
| 46 | MP0003075_altered_response_to | 1.41066419 |
| 47 | MP0002419_abnormal_innate_immunity | 1.39952302 |
| 48 | MP0002452_abnormal_antigen_presenting | 1.39143723 |
| 49 | MP0002420_abnormal_adaptive_immunity | 1.37415879 |
| 50 | MP0000689_abnormal_spleen_morphology | 1.37182646 |
| 51 | MP0001819_abnormal_immune_cell | 1.36426598 |
| 52 | MP0002132_abnormal_respiratory_system | 1.36376206 |
| 53 | MP0002398_abnormal_bone_marrow | 1.36030813 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.34835556 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.34835556 |
| 56 | MP0006082_CNS_inflammation | 1.34446047 |
| 57 | MP0002148_abnormal_hypersensitivity_rea | 1.34427286 |
| 58 | MP0005387_immune_system_phenotype | 1.33999192 |
| 59 | MP0001790_abnormal_immune_system | 1.33999192 |
| 60 | MP0001853_heart_inflammation | 1.33750952 |
| 61 | MP0005451_abnormal_body_composition | 1.32175990 |
| 62 | MP0001845_abnormal_inflammatory_respons | 1.31652438 |
| 63 | MP0005636_abnormal_mineral_homeostasis | 1.31623547 |
| 64 | MP0004019_abnormal_vitamin_homeostasis | 1.31074330 |
| 65 | MP0010155_abnormal_intestine_physiology | 1.27268392 |
| 66 | MP0000490_abnormal_crypts_of | 1.26906833 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 1.26039284 |
| 68 | MP0002722_abnormal_immune_system | 1.22821732 |
| 69 | MP0000716_abnormal_immune_system | 1.21768567 |
| 70 | MP0005084_abnormal_gallbladder_morpholo | 1.20878057 |
| 71 | MP0003111_abnormal_nucleus_morphology | 1.20749834 |
| 72 | MP0000703_abnormal_thymus_morphology | 1.19695145 |
| 73 | MP0002429_abnormal_blood_cell | 1.18121631 |
| 74 | MP0003183_abnormal_peptide_metabolism | 1.18020637 |
| 75 | MP0001873_stomach_inflammation | 1.17946343 |
| 76 | MP0003724_increased_susceptibility_to | 1.17844486 |
| 77 | MP0008058_abnormal_DNA_repair | 1.15637543 |
| 78 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14670806 |
| 79 | MP0003077_abnormal_cell_cycle | 1.14520736 |
| 80 | MP0000598_abnormal_liver_morphology | 1.08883144 |
| 81 | MP0004947_skin_inflammation | 1.07971609 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 1.06721741 |
| 83 | MP0003866_abnormal_defecation | 1.05761500 |
| 84 | MP0001986_abnormal_taste_sensitivity | 1.05326016 |
| 85 | MP0002118_abnormal_lipid_homeostasis | 1.04265616 |
| 86 | MP0006035_abnormal_mitochondrial_morpho | 1.03243579 |
| 87 | MP0002405_respiratory_system_inflammati | 1.02318885 |
| 88 | MP0010094_abnormal_chromosome_stability | 1.00228589 |
| 89 | MP0008004_abnormal_stomach_pH | 0.99898053 |
| 90 | MP0009764_decreased_sensitivity_to | 0.98212066 |
| 91 | MP0009763_increased_sensitivity_to | 0.97888106 |
| 92 | MP0009697_abnormal_copulation | 0.97732174 |
| 93 | MP0004782_abnormal_surfactant_physiolog | 0.97545808 |
| 94 | MP0002019_abnormal_tumor_incidence | 0.94645692 |
| 95 | MP0005167_abnormal_blood-brain_barrier | 0.92011643 |
| 96 | MP0000015_abnormal_ear_pigmentation | 0.90594413 |
| 97 | MP0002166_altered_tumor_susceptibility | 0.89371599 |
| 98 | MP0000604_amyloidosis | 0.88855726 |
| 99 | MP0005535_abnormal_body_temperature | 0.86538602 |
| 100 | MP0000858_altered_metastatic_potential | 0.85606717 |
| 101 | MP0001533_abnormal_skeleton_physiology | 0.83707197 |
| 102 | MP0001663_abnormal_digestive_system | 0.83303361 |
| 103 | MP0003300_gastrointestinal_ulcer | 0.83219528 |
| 104 | MP0009642_abnormal_blood_homeostasis | 0.81824013 |
| 105 | MP0009379_abnormal_foot_pigmentation | 0.81822187 |
| 106 | MP0001756_abnormal_urination | 0.81299265 |
| 107 | MP0000343_altered_response_to | 0.77649055 |
| 108 | MP0000465_gastrointestinal_hemorrhage | 0.75358658 |
| 109 | MP0002277_abnormal_respiratory_mucosa | 0.74849934 |
| 110 | MP0003786_premature_aging | 0.74402934 |
| 111 | MP0005646_abnormal_pituitary_gland | 0.74294069 |
| 112 | MP0004381_abnormal_hair_follicle | 0.73847685 |
| 113 | MP0001905_abnormal_dopamine_level | 0.73808760 |
| 114 | MP0001968_abnormal_touch/_nociception | 0.72765966 |
| 115 | MP0005376_homeostasis/metabolism_phenot | 0.72609468 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.72235419 |
| 117 | MP0005410_abnormal_fertilization | 0.71149486 |
| 118 | MP0001765_abnormal_ion_homeostasis | 0.69562871 |
| 119 | MP0005166_decreased_susceptibility_to | 0.69491605 |
| 120 | MP0005220_abnormal_exocrine_pancreas | 0.68886491 |
| 121 | MP0002006_tumorigenesis | 0.68432341 |
| 122 | MP0008872_abnormal_physiological_respon | 0.67125656 |
| 123 | MP0008873_increased_physiological_sensi | 0.67080967 |
| 124 | MP0005645_abnormal_hypothalamus_physiol | 0.67008392 |
| 125 | MP0003638_abnormal_response/metabolism_ | 0.66153809 |
| 126 | MP0005390_skeleton_phenotype | 0.65587103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.51147128 |
| 2 | Prolonged bleeding time (HP:0003010) | 4.49566212 |
| 3 | Stomatitis (HP:0010280) | 4.25976458 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.71189230 |
| 5 | Myositis (HP:0100614) | 3.59594276 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 3.52927969 |
| 7 | Hepatic necrosis (HP:0002605) | 3.50572926 |
| 8 | Chronic obstructive pulmonary disease (HP:0006510) | 3.46867524 |
| 9 | Obstructive lung disease (HP:0006536) | 3.46867524 |
| 10 | Recurrent fungal infections (HP:0002841) | 3.32210434 |
| 11 | Hepatocellular necrosis (HP:0001404) | 3.28576983 |
| 12 | Generalized aminoaciduria (HP:0002909) | 3.26975725 |
| 13 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.25739857 |
| 14 | Gingival bleeding (HP:0000225) | 3.25082973 |
| 15 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.17416727 |
| 16 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.17416727 |
| 17 | Abnormal number of erythroid precursors (HP:0012131) | 3.17403718 |
| 18 | Agammaglobulinemia (HP:0004432) | 3.15512251 |
| 19 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.12968121 |
| 20 | Panhypogammaglobulinemia (HP:0003139) | 3.12110949 |
| 21 | Meningitis (HP:0001287) | 3.11130520 |
| 22 | Abnormality of B cell number (HP:0010975) | 3.08156928 |
| 23 | Hypobetalipoproteinemia (HP:0003563) | 3.03915440 |
| 24 | Prolonged partial thromboplastin time (HP:0003645) | 3.03307300 |
| 25 | B lymphocytopenia (HP:0010976) | 2.98865774 |
| 26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.94339307 |
| 27 | Increased IgE level (HP:0003212) | 2.91676247 |
| 28 | Nausea (HP:0002018) | 2.89705078 |
| 29 | Orchitis (HP:0100796) | 2.89456055 |
| 30 | Encephalitis (HP:0002383) | 2.88956469 |
| 31 | Intrahepatic cholestasis (HP:0001406) | 2.80731170 |
| 32 | Xanthomatosis (HP:0000991) | 2.72727603 |
| 33 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.70071460 |
| 34 | Recurrent viral infections (HP:0004429) | 2.68180149 |
| 35 | Autoimmune hemolytic anemia (HP:0001890) | 2.67894611 |
| 36 | Deep venous thrombosis (HP:0002625) | 2.67834668 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 2.67246303 |
| 38 | Inflammation of the large intestine (HP:0002037) | 2.66559494 |
| 39 | Gastrointestinal inflammation (HP:0004386) | 2.65993543 |
| 40 | Mitochondrial inheritance (HP:0001427) | 2.65718214 |
| 41 | Granulocytopenia (HP:0001913) | 2.64517864 |
| 42 | Pustule (HP:0200039) | 2.64307299 |
| 43 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.62768318 |
| 44 | IgG deficiency (HP:0004315) | 2.62635739 |
| 45 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.62036215 |
| 46 | Hyperlipoproteinemia (HP:0010980) | 2.61815012 |
| 47 | Hyperammonemia (HP:0001987) | 2.60466506 |
| 48 | Reduced antithrombin III activity (HP:0001976) | 2.60284691 |
| 49 | Increased serum ferritin (HP:0003281) | 2.59850299 |
| 50 | Optic neuritis (HP:0100653) | 2.59557158 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.59557158 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.59177823 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.59177823 |
| 54 | 3-Methylglutaconic aciduria (HP:0003535) | 2.59129331 |
| 55 | Increased IgM level (HP:0003496) | 2.58181639 |
| 56 | Petechiae (HP:0000967) | 2.58142920 |
| 57 | Severe combined immunodeficiency (HP:0004430) | 2.57555180 |
| 58 | Hyperbilirubinemia (HP:0002904) | 2.57187846 |
| 59 | Cerebral edema (HP:0002181) | 2.52488487 |
| 60 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.52279766 |
| 61 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.51597224 |
| 62 | Vasculitis (HP:0002633) | 2.51130446 |
| 63 | Acute hepatic failure (HP:0006554) | 2.50361676 |
| 64 | Abnormality of T cells (HP:0002843) | 2.49780091 |
| 65 | Increased cerebral lipofuscin (HP:0011813) | 2.48569477 |
| 66 | Increased CSF lactate (HP:0002490) | 2.48442574 |
| 67 | Hyperglycinemia (HP:0002154) | 2.48411935 |
| 68 | Systemic lupus erythematosus (HP:0002725) | 2.47831762 |
| 69 | Dysostosis multiplex (HP:0000943) | 2.46299241 |
| 70 | Lethargy (HP:0001254) | 2.45630422 |
| 71 | Abnormality of iron homeostasis (HP:0011031) | 2.44882928 |
| 72 | Increased serum lactate (HP:0002151) | 2.44193555 |
| 73 | Cellulitis (HP:0100658) | 2.43541540 |
| 74 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.42879324 |
| 75 | Thrombocytosis (HP:0001894) | 2.42654488 |
| 76 | Recurrent skin infections (HP:0001581) | 2.42131759 |
| 77 | Abnormality of the prostate (HP:0008775) | 2.41776555 |
| 78 | Recurrent cutaneous fungal infections (HP:0011370) | 2.41149798 |
| 79 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.41149798 |
| 80 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.39531781 |
| 81 | Abnormality of macrophages (HP:0004311) | 2.39483982 |
| 82 | Acute encephalopathy (HP:0006846) | 2.39255471 |
| 83 | Hyperglycinuria (HP:0003108) | 2.38398957 |
| 84 | Hepatosplenomegaly (HP:0001433) | 2.38045826 |
| 85 | Episodic fever (HP:0001954) | 2.37924352 |
| 86 | Recurrent bacterial skin infections (HP:0005406) | 2.37905366 |
| 87 | Hypergammaglobulinemia (HP:0010702) | 2.37757352 |
| 88 | Lactic acidosis (HP:0003128) | 2.37524012 |
| 89 | Recurrent abscess formation (HP:0002722) | 2.35873225 |
| 90 | Gastrointestinal infarctions (HP:0005244) | 2.34654081 |
| 91 | Leukocytosis (HP:0001974) | 2.33766422 |
| 92 | Abnormality of methionine metabolism (HP:0010901) | 2.32719681 |
| 93 | Urticaria (HP:0001025) | 2.32527101 |
| 94 | Menorrhagia (HP:0000132) | 2.32521982 |
| 95 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.31929197 |
| 96 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.29308262 |
| 97 | Abnormality of nucleobase metabolism (HP:0010932) | 2.29204997 |
| 98 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.28610535 |
| 99 | Hypertensive crisis (HP:0100735) | 2.24784108 |
| 100 | Acute necrotizing encephalopathy (HP:0006965) | 2.24695065 |
| 101 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.24636224 |
| 102 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.24033424 |
| 103 | Joint hemorrhage (HP:0005261) | 2.22993956 |
| 104 | IgM deficiency (HP:0002850) | 2.22157111 |
| 105 | Macrocytic anemia (HP:0001972) | 2.21078958 |
| 106 | Microcytic anemia (HP:0001935) | 2.19115350 |
| 107 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.18476004 |
| 108 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.18476004 |
| 109 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.18476004 |
| 110 | Brushfield spots (HP:0001088) | 2.17874116 |
| 111 | Pulmonary infiltrates (HP:0002113) | 2.16119352 |
| 112 | Increased intramyocellular lipid droplets (HP:0012240) | 2.14992083 |
| 113 | CNS demyelination (HP:0007305) | 2.14291430 |
| 114 | Increased muscle lipid content (HP:0009058) | 2.10346594 |
| 115 | Glycosuria (HP:0003076) | 2.10135589 |
| 116 | Abnormality of urine glucose concentration (HP:0011016) | 2.10135589 |
| 117 | Skin rash (HP:0000988) | 2.09756327 |
| 118 | Reticulocytopenia (HP:0001896) | 2.09289155 |
| 119 | Eczematoid dermatitis (HP:0000976) | 2.05830611 |
| 120 | Cerebral palsy (HP:0100021) | 2.05467204 |
| 121 | Joint swelling (HP:0001386) | 2.05351364 |
| 122 | Abnormality of glycine metabolism (HP:0010895) | 2.04247680 |
| 123 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.04247680 |
| 124 | Abnormality of T cell physiology (HP:0011840) | 2.04146657 |
| 125 | Type I transferrin isoform profile (HP:0003642) | 2.03750406 |
| 126 | Chest pain (HP:0100749) | 2.03430543 |
| 127 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.02949973 |
| 128 | Oral leukoplakia (HP:0002745) | 2.02847230 |
| 129 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.01465423 |
| 130 | Eosinophilia (HP:0001880) | 2.01231472 |
| 131 | Hypolipoproteinemia (HP:0010981) | 2.01223161 |
| 132 | Hypoglycemic coma (HP:0001325) | 2.01060695 |
| 133 | Spontaneous hematomas (HP:0007420) | 2.00834819 |
| 134 | Purpura (HP:0000979) | 2.00811520 |
| 135 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.00701720 |
| 136 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.00701720 |
| 137 | Abnormal protein glycosylation (HP:0012346) | 2.00701720 |
| 138 | Abnormal glycosylation (HP:0012345) | 2.00701720 |
| 139 | Gout (HP:0001997) | 2.00357064 |
| 140 | Poikilocytosis (HP:0004447) | 1.99506082 |
| 141 | Lipid accumulation in hepatocytes (HP:0006561) | 1.99105485 |
| 142 | Abnormal platelet volume (HP:0011876) | 1.99082582 |
| 143 | Abnormality of the anterior horn cell (HP:0006802) | 1.98460870 |
| 144 | Degeneration of anterior horn cells (HP:0002398) | 1.98460870 |
| 145 | Combined immunodeficiency (HP:0005387) | 1.97077434 |
| 146 | Abnormality of serum amino acid levels (HP:0003112) | 1.96908838 |
| 147 | Pallor (HP:0000980) | 1.96741608 |
| 148 | Neutropenia (HP:0001875) | 1.96434365 |
| 149 | Severe visual impairment (HP:0001141) | 1.96386907 |
| 150 | J-shaped sella turcica (HP:0002680) | 1.95353316 |
| 151 | Mucopolysacchariduria (HP:0008155) | 1.94885990 |
| 152 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94885990 |
| 153 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.94468117 |
| 154 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.94468117 |
| 155 | Abnormality of glycolipid metabolism (HP:0010969) | 1.94468117 |
| 156 | Fat malabsorption (HP:0002630) | 1.93676213 |
| 157 | Epistaxis (HP:0000421) | 1.93206846 |
| 158 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.93046838 |
| 159 | Abnormality of eosinophils (HP:0001879) | 1.92280101 |
| 160 | Increased hepatocellular lipid droplets (HP:0006565) | 1.91565763 |
| 161 | Sepsis (HP:0100806) | 1.90899262 |
| 162 | Lymphopenia (HP:0001888) | 1.90811847 |
| 163 | Metabolic acidosis (HP:0001942) | 1.90690492 |
| 164 | Respiratory failure (HP:0002878) | 1.90427943 |
| 165 | Autoimmune thrombocytopenia (HP:0001973) | 1.89069135 |
| 166 | Renal Fanconi syndrome (HP:0001994) | 1.88876188 |
| 167 | Abnormality of the peritoneum (HP:0002585) | 1.88840342 |
| 168 | Birth length less than 3rd percentile (HP:0003561) | 1.88461999 |
| 169 | Microvesicular hepatic steatosis (HP:0001414) | 1.87520892 |
| 170 | Ketosis (HP:0001946) | 1.87400763 |
| 171 | Abnormality of purine metabolism (HP:0004352) | 1.87323434 |
| 172 | Abnormality of the common coagulation pathway (HP:0010990) | 1.86409318 |
| 173 | Pulmonary fibrosis (HP:0002206) | 1.84899835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.05233042 |
| 2 | BCKDK | 3.65345039 |
| 3 | BUB1 | 2.91000272 |
| 4 | MAP4K1 | 2.71489646 |
| 5 | STK16 | 2.58717807 |
| 6 | PIM2 | 2.54704996 |
| 7 | EIF2AK1 | 2.37526233 |
| 8 | ERN1 | 2.28174756 |
| 9 | FES | 2.23764447 |
| 10 | TESK2 | 2.04368151 |
| 11 | BRSK2 | 2.03987009 |
| 12 | ARAF | 2.01394920 |
| 13 | TNK2 | 1.99515126 |
| 14 | MAP3K14 | 1.92291904 |
| 15 | TBK1 | 1.92031656 |
| 16 | WEE1 | 1.84469972 |
| 17 | RPS6KA4 | 1.81119003 |
| 18 | KDR | 1.73977884 |
| 19 | IKBKE | 1.72141576 |
| 20 | TXK | 1.70785678 |
| 21 | TYK2 | 1.67797083 |
| 22 | DYRK3 | 1.67644283 |
| 23 | EIF2AK3 | 1.63507797 |
| 24 | BRAF | 1.57535727 |
| 25 | MAP3K12 | 1.57376974 |
| 26 | MAP2K3 | 1.53386047 |
| 27 | IRAK4 | 1.53229911 |
| 28 | ZAP70 | 1.52086842 |
| 29 | MAP3K11 | 1.51726927 |
| 30 | ACVR1B | 1.49408540 |
| 31 | BLK | 1.41230795 |
| 32 | CSK | 1.39969510 |
| 33 | IRAK3 | 1.38216107 |
| 34 | BRSK1 | 1.38079170 |
| 35 | BMPR1B | 1.36808307 |
| 36 | GRK6 | 1.36052089 |
| 37 | PIK3CG | 1.35692506 |
| 38 | TEC | 1.28201837 |
| 39 | VRK1 | 1.26695234 |
| 40 | ABL2 | 1.21657890 |
| 41 | MST1R | 1.19471991 |
| 42 | TAOK3 | 1.17132204 |
| 43 | BTK | 1.16251688 |
| 44 | HCK | 1.15488535 |
| 45 | VRK2 | 1.13440282 |
| 46 | NEK2 | 1.12566356 |
| 47 | SCYL2 | 1.12215794 |
| 48 | CAMKK2 | 1.11827761 |
| 49 | SYK | 1.09724072 |
| 50 | PLK4 | 1.08874312 |
| 51 | IKBKB | 1.08053981 |
| 52 | MAP3K13 | 1.07552350 |
| 53 | MAP2K6 | 1.06060622 |
| 54 | PIM1 | 1.04963091 |
| 55 | KIT | 0.98171790 |
| 56 | EPHA2 | 0.97702699 |
| 57 | MAPK11 | 0.96000175 |
| 58 | MAP4K2 | 0.93120977 |
| 59 | NUAK1 | 0.90484963 |
| 60 | TAOK1 | 0.86604905 |
| 61 | CDK8 | 0.86476844 |
| 62 | MATK | 0.86112823 |
| 63 | MAP3K1 | 0.84217682 |
| 64 | BMPR2 | 0.82793676 |
| 65 | SIK3 | 0.82199218 |
| 66 | TAOK2 | 0.81683871 |
| 67 | GRK5 | 0.81330229 |
| 68 | FLT3 | 0.80719964 |
| 69 | PRKCQ | 0.80693409 |
| 70 | TSSK6 | 0.80080807 |
| 71 | AURKB | 0.78144727 |
| 72 | FGFR4 | 0.77625970 |
| 73 | AURKA | 0.77539724 |
| 74 | TLK1 | 0.77071757 |
| 75 | PRKG2 | 0.75194405 |
| 76 | BMX | 0.74438362 |
| 77 | MAP2K2 | 0.74364637 |
| 78 | CDC7 | 0.74122767 |
| 79 | PLK1 | 0.72907853 |
| 80 | JAK2 | 0.67858640 |
| 81 | JAK3 | 0.67754083 |
| 82 | LYN | 0.66935053 |
| 83 | MAP3K3 | 0.65897768 |
| 84 | LRRK2 | 0.65844657 |
| 85 | SIK2 | 0.64766053 |
| 86 | DAPK1 | 0.64752542 |
| 87 | CCNB1 | 0.62811246 |
| 88 | NEK1 | 0.62323561 |
| 89 | RIPK4 | 0.61646559 |
| 90 | RPS6KB2 | 0.61173892 |
| 91 | MYLK | 0.60042861 |
| 92 | IRAK2 | 0.59655451 |
| 93 | PTK2B | 0.59252289 |
| 94 | CDK4 | 0.58560703 |
| 95 | ADRBK2 | 0.58537340 |
| 96 | CHUK | 0.58341523 |
| 97 | TESK1 | 0.58162086 |
| 98 | PRKCI | 0.58010243 |
| 99 | NME1 | 0.57516017 |
| 100 | DAPK2 | 0.54191828 |
| 101 | DAPK3 | 0.53953352 |
| 102 | RPS6KA6 | 0.53912340 |
| 103 | MAPKAPK3 | 0.53421290 |
| 104 | RPS6KA5 | 0.53009740 |
| 105 | PDK1 | 0.52593452 |
| 106 | NLK | 0.52429169 |
| 107 | STK10 | 0.52249000 |
| 108 | JAK1 | 0.51697810 |
| 109 | PRPF4B | 0.51143309 |
| 110 | MAPK12 | 0.51138082 |
| 111 | PDPK1 | 0.51093818 |
| 112 | NEK9 | 0.51089230 |
| 113 | STK4 | 0.50607292 |
| 114 | MARK3 | 0.49082428 |
| 115 | FGR | 0.48920078 |
| 116 | DYRK1B | 0.48405632 |
| 117 | LCK | 0.48227495 |
| 118 | FYN | 0.48196613 |
| 119 | ITK | 0.47570383 |
| 120 | GRK7 | 0.47521810 |
| 121 | SRPK1 | 0.46469183 |
| 122 | RAF1 | 0.45185936 |
| 123 | EPHB1 | 0.44921072 |
| 124 | PBK | 0.44666536 |
| 125 | MST4 | 0.44617920 |
| 126 | CDK9 | 0.44467483 |
| 127 | CAMKK1 | 0.44290310 |
| 128 | CSNK2A1 | 0.43502585 |
| 129 | MAPKAPK2 | 0.42443160 |
| 130 | TGFBR1 | 0.42229342 |
| 131 | CSNK1G3 | 0.42100070 |
| 132 | PRKCD | 0.42067594 |
| 133 | ILK | 0.41233624 |
| 134 | MAP3K8 | 0.39944168 |
| 135 | EIF2AK2 | 0.39844449 |
| 136 | GRK1 | 0.38700526 |
| 137 | CSF1R | 0.37527597 |
| 138 | RPS6KC1 | 0.37334706 |
| 139 | IRAK1 | 0.37057669 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.43364958 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 2.83574940 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.77193318 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.63523800 |
| 5 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.44422592 |
| 6 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.38875913 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.37191428 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.32255119 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.29125227 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 2.05480213 |
| 11 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.01857928 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.96172210 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.95796318 |
| 14 | Sulfur relay system_Homo sapiens_hsa04122 | 1.95279701 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.93132912 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.91267466 |
| 17 | DNA replication_Homo sapiens_hsa03030 | 1.87350262 |
| 18 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.85534379 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.84227556 |
| 20 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.83495058 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.74484893 |
| 22 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.70660044 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.70586021 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.70571368 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.68342290 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.67348630 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.62712352 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.62240426 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.57278028 |
| 30 | Protein export_Homo sapiens_hsa03060 | 1.52512719 |
| 31 | Mismatch repair_Homo sapiens_hsa03430 | 1.52465491 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.51224774 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.50590414 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.50140602 |
| 35 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.48837044 |
| 36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.47944806 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.47447528 |
| 38 | Base excision repair_Homo sapiens_hsa03410 | 1.43220096 |
| 39 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.42884688 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.40197624 |
| 41 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.38171881 |
| 42 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.37973924 |
| 43 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.36846454 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.36396655 |
| 45 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.36305237 |
| 46 | Homologous recombination_Homo sapiens_hsa03440 | 1.31504151 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 1.30669581 |
| 48 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.30202252 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.29094180 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.26979357 |
| 51 | Lysosome_Homo sapiens_hsa04142 | 1.26529578 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.26326471 |
| 53 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.26085310 |
| 54 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.25733339 |
| 55 | Parkinsons disease_Homo sapiens_hsa05012 | 1.25161536 |
| 56 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.24090507 |
| 57 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.23206175 |
| 58 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.22579242 |
| 59 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.19363642 |
| 60 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.18942940 |
| 61 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.16597508 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.15962040 |
| 63 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.15722549 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.14902906 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.14894752 |
| 66 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14150786 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 1.12156476 |
| 68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.12022518 |
| 69 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.11624948 |
| 70 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.09332450 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.08614979 |
| 72 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.07543214 |
| 73 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.07383223 |
| 74 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.07345747 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.06993615 |
| 76 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.04054336 |
| 77 | Malaria_Homo sapiens_hsa05144 | 1.03770622 |
| 78 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.03434417 |
| 79 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.02394633 |
| 80 | Phagosome_Homo sapiens_hsa04145 | 0.94746477 |
| 81 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.94563563 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94039142 |
| 83 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.92485200 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.92304886 |
| 85 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.91876005 |
| 86 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.91282063 |
| 87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90007613 |
| 88 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.89573281 |
| 89 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.88297738 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.87578353 |
| 91 | Shigellosis_Homo sapiens_hsa05131 | 0.87302367 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.86849252 |
| 93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.85717055 |
| 94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85221408 |
| 95 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.84406257 |
| 96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.82159061 |
| 97 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.82109576 |
| 98 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.81328368 |
| 99 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.81184346 |
| 100 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.80821368 |
| 101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.79439106 |
| 102 | Purine metabolism_Homo sapiens_hsa00230 | 0.79173015 |
| 103 | Other glycan degradation_Homo sapiens_hsa00511 | 0.78742330 |
| 104 | Spliceosome_Homo sapiens_hsa03040 | 0.78620603 |
| 105 | Legionellosis_Homo sapiens_hsa05134 | 0.78119249 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.76361968 |
| 107 | Retinol metabolism_Homo sapiens_hsa00830 | 0.75184191 |
| 108 | RNA transport_Homo sapiens_hsa03013 | 0.73980593 |
| 109 | Huntingtons disease_Homo sapiens_hsa05016 | 0.73035345 |
| 110 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.72660768 |
| 111 | Influenza A_Homo sapiens_hsa05164 | 0.70965823 |
| 112 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70089979 |
| 113 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.68289416 |
| 114 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.67721177 |
| 115 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.67460654 |
| 116 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.67032452 |
| 117 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.66080839 |
| 118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66042853 |
| 119 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.65561799 |
| 120 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64594082 |
| 121 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.64057798 |
| 122 | Alzheimers disease_Homo sapiens_hsa05010 | 0.63620887 |
| 123 | Endocytosis_Homo sapiens_hsa04144 | 0.63520698 |
| 124 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.63391183 |
| 125 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.62344190 |
| 126 | ABC transporters_Homo sapiens_hsa02010 | 0.61306519 |
| 127 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58610785 |
| 128 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58340309 |
| 129 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.58266485 |
| 130 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.57404261 |
| 131 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.55958745 |
| 132 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.55753602 |
| 133 | Apoptosis_Homo sapiens_hsa04210 | 0.54923579 |
| 134 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54503562 |
| 135 | Salmonella infection_Homo sapiens_hsa05132 | 0.54280984 |
| 136 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53373327 |
| 137 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49684460 |
| 138 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.49377216 |
| 139 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49225946 |
| 140 | Measles_Homo sapiens_hsa05162 | 0.49213033 |
| 141 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.48950471 |
| 142 | Leishmaniasis_Homo sapiens_hsa05140 | 0.47116658 |
| 143 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.46551848 |
| 144 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45714354 |
| 145 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45655015 |
| 146 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.44976754 |
| 147 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44877222 |
| 148 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44633759 |
| 149 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44397839 |
| 150 | Hepatitis C_Homo sapiens_hsa05160 | 0.44184001 |
| 151 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.43266308 |
| 152 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43226920 |
| 153 | Cell cycle_Homo sapiens_hsa04110 | 0.41857905 |
| 154 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40578296 |
| 155 | Allograft rejection_Homo sapiens_hsa05330 | 0.40483066 |
| 156 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39810491 |
| 157 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.34372424 |

